VREX

Varex Imaging Corporation [VREX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

VREX Stock Summary

In the News

04:05 29 Mar 2024 VREX

Varex to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Virtual Conference

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Oppenheimer 34th Annual Healthcare MedTech & Services Virtual Conference. Management will be participating in a fireside chat on Tuesday, March 12, 2024 at 1:20pm EDT. The webcast can be accessed here or on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging.

11:25 29 Mar 2024 VREX

Varex Imaging Corporation (VREX) Q1 2024 Earnings Call Transcript

Varex Imaging Corporation (VREX) Q1 2024 Earnings Call Transcript

07:20 29 Mar 2024 VREX

VAREX IMAGING (VREX) Lags Q1 Earnings Estimates

VAREX IMAGING (VREX) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.08 per share a year ago.

09:05 29 Mar 2024 VREX

Varex to Present at CJS Securities 24th Annual New Ideas for the New Year Virtual Conference

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at CJS Securities 24th Annual New Ideas for the New Year Virtual Conference. Management will be presenting on Wednesday, January 10, 2024 at 3:05pm EST. Further details of the conference can be found on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, whi.

09:05 29 Mar 2024 VREX

Varex to Participate in Two Investor Conferences

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to participate in two upcoming investor conferences. 6th Annual Evercore ISI HealthCONx Conference – November 30, 2023 (Fireside chat & 1x1s) Mizuho Medical Devices & Healthcare Services Summit 2023 – December 6, 2023 (Virtual 1x1s). More details can be accessed through Varex's website at www.vareximaging.com/news on the dates listed above. About Varex Varex Imaging Cor.

09:38 29 Mar 2024 VREX

Varex Imaging Corporation (VREX) Q4 2023 Earnings Call Transcript

Varex Imaging Corporation (NASDAQ:VREX ) Q4 2023 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants Christopher Belfiore – Director-Investor Relations Sunny Sanyal – President and Chief Executive Officer Sam Maheshwari – Chief Financial Officer Conference Call Participants James Sidoti – Sidoti & Company Larry Solow – CJS Suraj Kalia – Oppenheimer Anthony Petrone – Mizuho Operator Greetings, and welcome to the Varex Fourth Quarter and Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

09:05 29 Mar 2024 VREX

Varex Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and full fiscal year 2023 following the close of regular trading on Tuesday, November 14, 2023. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also acc.

05:52 29 Mar 2024 VREX

5 Best Penny Stock Alternatives To Buy In October 2023

Penny stocks can be tempting because of their low price, but investors should beware. Here's why you should avoid them, plus five alternative investments with better risk/reward profiles.

09:05 29 Mar 2024 VREX

Varex to Present at the Sidoti Small Cap Virtual Conference

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Sidoti Small Cap Virtual Conference. Management will participate in a fireside chat presentation on Wednesday, September 20, 2023 at 1:00pm EST. The presentation will be webcast live and may be accessed through the following link: https://sidoti.zoom.us/webinar/register/WN_b584FfbtSOy7pvg9PiEx5g A replay of the presentation will be available on Varex's website.

10:48 29 Mar 2024 VREX

Varex Imaging Corporation (VREX) Q3 2023 Earnings Call Transcript

Varex Imaging Corporation (NASDAQ:VREX ) Q3 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Christopher Belfiore - Investor Relations Sunny Sanyal - President and Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer & Company Larry Solow - CJS Young Li - Jefferies James Sidoti - Sidoti & Company Anthony Petrone - Mizuho Securities Operator Greetings. Welcome to the Varex Third Quarter Full Year 2023 Earnings Call.

VREX Financial details

Company Rating
Buy
Market Cap
698.32M
Income
44.6M
Revenue
877.8M
Book val./share
14.01
Cash/share
4.77
Dividend
-
Dividend %
-
Employees
2.3K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
16.91
Forward P/E
17.08
PEG
3.59
P/S
0.92
P/B
1.44
P/C
3.79
P/FCF
14.71
Quick Ratio
1.94
Current Ratio
4.04
Debt / Equity
0.83
LT Debt / Equity
0.8
-
-
EPS (TTM)
1.12
EPS next Y
1.06
EPS next Q
0.31
EPS this Y
57.89%
EPS next Y
-5.61%
EPS next 5Y
78.94%
EPS last 5Y
23.96%
Revenue last 5Y
2.74%
Revenue Q/Q
-16.45%
EPS Q/Q
-101.56%
-
-
-
-
SMA20
1.98%
SMA50
-12.91%
SMA100
-2.67%
Inst Own
82.31%
Inst Trans
0.78%
ROA
4%
ROE
9%
ROC
0.06%
Gross Margin
32%
Oper. Margin
8%
Profit Margin
5%
Payout
-
Shs Outstand
40.6M
Shs Float
40.14M
-
-
-
-
Target Price
-
52W Range
16.72-23.895
52W High
-21.3%
52W Low
+13.13%
RSI
58.36
Rel Volume
1.42
Avg Volume
336.72K
Volume
478.12K
Perf Week
3.31%
Perf Month
4.99%
Perf Quarter
-5.04%
Perf Half Y
-2.58%
-
-
-
-
Beta
0.695
-
-
Volatility
0.28%, 0.25%
Prev Close
2.67%
Price
18.1
Change
3.43%

VREX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-09-29

Metric History 2019-09-272020-10-022021-10-012022-09-30 2023-09-29
2.02K2.02K2.02K2.02K2.02K
Revenue per share
20.4319.0320.8221.5917.76
Net income per share
0.41-1.460.440.760.96
Operating cash flow per share
1.880.342.360.422.16
Free cash flow per share
1.36-0.271.97-0.111.74
Cash per share
0.782.593.682.613.85
Book value per share
11.6811.6412.313.411.29
Tangible book value per share
2.162.713.915.745.37
Share holders equity per share
11.6811.6412.313.411.29
Interest debt per share
10.913.312.7611.969.92
Market cap
1.08B479.96M1.12B841.37M945.14M
Enterprise value
1.45B863.86M1.44B1.19B1.26B
P/E ratio
69.7-8.4864.5527.7719.61
Price to sales ratio
1.380.651.370.981.06
POCF ratio
15.0236.3612.1349.798.72
PFCF ratio
20.74-46.614.49-191.2210.78
P/B Ratio
2.421.062.321.581.66
PTB ratio
2.421.062.321.581.66
EV to sales
1.851.171.761.381.41
Enterprise value over EBITDA
30.5-22.9720.3414.120.83
EV to operating cash flow
20.165.4415.5370.3211.64
EV to free cash flow
27.74-83.8718.55-270.0814.39
Earnings yield
0.01-0.120.020.040.05
Free cash flow yield
0.05-0.020.07-0.010.09
Debt to equity
0.891.070.950.820.83
Debt to assets
0.380.430.40.370.38
Net debt to EBITDA
7.7-10.214.454.125.23
Current ratio
2.513.253.333.524.04
Interest coverage
0.39-0.980.791.272.63
Income quality
4.55-0.235.170.552.23
Dividend Yield
00.11000
Payout ratio
0.03-0.940.070.090
Sales general and administrative to revenue
00000
Research and developement to revenue
0.10.110.090.090.09
Intangibles to total assets
0.360.320.30.270.25
Capex to operating cash flow
-0.28-1.78-0.16-1.26-0.19
Capex to revenue
-0.03-0.03-0.02-0.02-0.02
Capex to depreciation
-0.51-0.59-0.4-0.63-0.62
Stock based compensation to revenue
0.010.020.020.020.02
Graham number
10.3219.5511.0715.1515.6
ROIC
0.01-0.030.020.040.11
Return on tangible assets
0.02-0.070.020.030.05
Graham Net
-8.38-8.87-7.06-6.34-4.24
Working capital
265.2M361.4M387.6M436.8M495.5M
Tangible asset value
82.7M105.2M153.6M228.6M270.1M
Net current asset value
-140.7M-151.7M-96.8M-27.8M-10.3M
Invested capital
0.891.070.950.820.83
Average receivables
147.5M132.4M139.55M164.3M168.45M
Average payables
63.6M66.9M65.85M68.5M71.45M
Average inventory
242.7M261.1M248.35M264M290.35M
Days sales outstanding
65.9361.269.2973.666.84
Days payables outstanding
42.4348.5539.2649.5639.16
Days of inventory on hand
174.38181.07150.11192.17167.94
Receivables turnover
5.545.965.274.965.46
Payables turnover
8.67.529.37.369.32
Inventory turnover
2.092.022.431.92.17
ROE
0.03-0.130.040.060.08
Capex per share
-0.52-0.61-0.38-0.54-0.41

Quarterly Fundamentals Overview

Last date of statement is 2023-12-29 for Q1

Metric History 2022-12-302023-03-312023-06-302023-09-29 2023-12-29
2.02K2.02K2.02K2.02K2.02K
Revenue per share
5.135.684.614.54.68
Net income per share
0.080.10.180.63-0.01
Operating cash flow per share
-0.090.680.750.930.25
Free cash flow per share
-0.230.540.660.830
Cash per share
2.452.943.023.844.77
Book value per share
12.7612.9310.5511.2414.01
Tangible book value per share
5.115.344.575.356.66
Share holders equity per share
12.7612.9310.5511.2414.01
Interest debt per share
11.7811.729.459.4411.73
Market cap
814.03M731.24M1.19B948.9M832.3M
Enterprise value
1.2B1.09B1.54B1.27B1.16B
P/E ratio
65.6544.5932.647.44-416.15
Price to sales ratio
3.963.25.124.174.38
POCF ratio
-220.0126.7931.5120.1580.81
PFCF ratio
-88.4833.735.4622.76-8.32K
P/B Ratio
1.591.412.241.671.46
PTB ratio
1.591.412.241.671.46
EV to sales
5.824.786.635.576.11
Enterprise value over EBITDA
92.8172.2447.95154.3778.96
EV to operating cash flow
-323.5839.9640.8326.87112.69
EV to free cash flow
-130.1350.2745.9430.35-11.61K
Earnings yield
00.010.010.030
Free cash flow yield
-0.010.030.030.040
Debt to equity
0.910.890.880.830.83
Debt to assets
0.390.390.390.380.38
Net debt to EBITDA
29.7123.8110.9438.6522.34
Current ratio
3.863.934.034.044.3
Interest coverage
0.652.143.613.380.64
Income quality
-1.166.354.11.47-25.75
Dividend Yield
00000
Payout ratio
00.15000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.10.10.090.10.11
Intangibles to total assets
0.270.270.260.250.25
Capex to operating cash flow
1.49-0.21-0.11-0.11-1.01
Capex to revenue
-0.03-0.02-0.02-0.02-0.05
Capex to depreciation
-0.69-0.69-0.51-0.61-1.2
Stock based compensation to revenue
0.020.010.020.010.02
Graham number
4.715.456.5512.641.97
ROIC
00.010.010.730
Return on tangible assets
000.010.030
Graham Net
-6.96-6.59-4.83-4.22-5.33
Working capital
449.9M461.2M479.9M495.5M495.6M
Tangible asset value
205.1M214.8M230.2M270.1M270.5M
Net current asset value
-48.6M-39.5M-28.3M-10.3M-13.6M
Invested capital
0.910.890.880.830.83
Average receivables
165.6M158.7M161.4M163.45M151.6M
Average payables
82.2M80.2M74.4M69.65M69.2M
Average inventory
311.75M315.5M304.2M287.6M283.6M
Days sales outstanding
69.1262.9163.2964.7566.13
Days payables outstanding
54.5242.9543.0738.9849.91
Days of inventory on hand
202.58179.83171.86167.17196.19
Receivables turnover
1.31.431.421.391.36
Payables turnover
1.652.12.092.311.8
Inventory turnover
0.440.50.520.540.46
ROE
0.010.010.020.060
Capex per share
-0.14-0.14-0.08-0.11-0.26

VREX Frequently Asked Questions

What is Varex Imaging Corporation stock symbol ?

Varex Imaging Corporation is a US stock , located in Salt lake city of Ut and trading under the symbol VREX

What is Varex Imaging Corporation stock quote today ?

Varex Imaging Corporation stock price is $18.1 today.

Is Varex Imaging Corporation stock public?

Yes, Varex Imaging Corporation is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap